Streetbeat News

Products Services

STBX

Starbox Group has announced a new image-to-processing technology. The details of the technology and its potential applications have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:37 am

MRKR

Marker Therapeutics has announced non-clinical data for its lead multi-tumor-associated antigen (multiTAA)-specific T cell product candidate, MT-401, in an off-the-shelf setting. The company also provided an update on the clinical readiness for the off-the-shelf program.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:36 am

PASG

Passage Bio has announced interim data from the first eight patients with GM1 Gangliosidosis in the Imagine-1 study. The safety data up to 28 months showed that dose 1 & 2 of PBGM01 were well tolerated, with a favorable safety & immunological profile.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:36 am

PTN

Palatin has announced a partnership with UpScriptHealth to make its product Vyleesi available on UpScriptHealth's telehealth platform. This move is expected to increase the accessibility of Vyleesi to patients.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:34 am

LCID

Lucid Group, Inc. (NYSE:LCID) shares rose in premarket trading on Monday following the company's announcement of price reductions for three trims of its Lucid Air EV. The price cuts, ranging from $10,500 to $12,400, come after a disappointing delivery update in mid-July. Lucid is set to report its Q2 results after trading closes on Monday, with an expected loss of $0.33 per share on revenue of $175.01 million, a 79.80% increase from a year ago.

Portfolio Pulse from Shanthi Rexaline

August 07, 2023 | 11:28 am

TNXP

Tonix Pharmaceuticals has completed the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL, a potential treatment for fibromyalgia-type long Covid. The topline results are expected to be released in Q3 of 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:24 am

PRAX

Praxis Precision Medicines has announced that an analysis of EEG activity for subjects in their recent Phase 1 study showed pharmacodynamic activity across all dose levels who received PRAX-628 at first administration, compared with subjects who received a placebo.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:20 am

CSTL

Castle Biosciences has announced that a new study published in The American Journal of Gastroenterology shows that its TissueCypher Barrett's Esophagus Test can improve management decisions for patients with low-grade dysplasia, leading to improved health outcomes.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:16 am

AAPL

AMZN

DKNG

GOOGL

HSIC

MSFT

NVDA

TSLA

TSN

The article covers a range of topics including US markets, crypto, US politics, world politics, US economy, tech, electric vehicles, consumer, communication, and general news. Key highlights include Tyson Foods, Henry Schein, Apple, Microsoft, Tesla, Nvidia, Amazon, Google, and DraftKings. In crypto, Bitcoin, Ethereum, and Dogecoin are mentioned. In politics, DeSantis, GOP Presidential Candidate, Bill Barr, and Trump are discussed. In tech, Apple's iPhone 15 and M3-Powered Mac Mini are highlighted. In electric vehicles, Tesla's revenue growth and diner plans are mentioned.

Portfolio Pulse from Akanksha Bakshi

August 07, 2023 | 11:08 am

VTRS

The FDA has accepted a new drug application from Viatris and Mapi Pharma for Ga Depot 40 Mg, a once-monthly injection for relapsing forms of multiple sclerosis. The PDUF action date is set for March 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 10:56 am